IIT Kanpur licensed the technology to Reliance Life Sciences Pvt. Ltd. and this marks the first time a gene therapy related technology has been developed and transferred from an academic institution to a company in India.
Cases and Conversations™: New Treatment Strategies for nAMD & DME
Community Practice Connections™: Inflammation & Pathogenesis in DME – Rethinking the Traditional Treatment Paradigm
Ophthalmology Consultations™: Keeping an Eye Out for MGD-Associated Dry Eye in Pre/Post-Op Patients – Improving Surgical Outcomes by Optimizing the Surface
(COPE Credit) Community Practice Connections™: Understanding Emerging Options in MGD-Associated Dry Eye Disease—Preparing for an Updated Armamentarium
Comprehensive Key Advances in Biosimilars for Retinal Diseases – Reviewing the Evidence, Addressing Patient Perspectives, and Practice Utilization for the Retina Specialist
Cases & Conversations™: Inflammation & Pathogenesis in DME – Rethinking the Traditional Treatment Paradigm
(CME Credit) Community Practice Connections™: Understanding Emerging Options in MGD-Associated Dry Eye Disease—Preparing for an Updated Armamentarium
(COPE Credit) Expert Illustrations & Commentaries™: Visualizing the Angiopoetin-Tie2 Pathway as a Target in Retinal and Choroidal Vascular Diseases
Alkeus announces funding and the appointment of Joshua Boger to executive chairmanJune 7th 2023
The $150 Million Series B funding will allow for the registration and launch of gilderuretinol, the first and only medicine in clinical development to address the underlying mechanism of Stargardt disease.
Glaukos achieves pipeline milestone with enrollment completion in phase 3 confirmatory trial for EpioxaJune 6th 2023
The company completed enrollment in less than 6 months from the trial commencement. The phase 3 trial results combined with the completion of the first phase 3 trial are expected to support the company’s targeted NDA submission for Epioxa by the end of 2024.
Kaustabh Ghosh, PhD, announced as the recipient of the Catalyst Award for innovative approaches for age-related macular degeneration.June 4th 2023
Doheny Eye Institute announced Ghosh was recognized by Research to Prevent Blindness and the International Retinal Research Foundation.
For LGBTQ+ ophthalmologists, truth has often had consequencesJune 2nd 2023
For Michael A. Puente Jr., MD, being open about himself and advocating for an overlooked community hasn’t always been as easy as it is today. Progress has been incremental, but he is optimistic about the state of ophthalmology for LGBTQ+ physicians and patients.